Quest Diagnostics Incorporated (DGX)
NYSE: DGX · IEX Real-Time Price · USD
136.64
-0.45 (-0.33%)
At close: Jul 2, 2024, 4:00 PM
137.62
+0.98 (0.72%)
After-hours: Jul 2, 2024, 7:59 PM EDT

Quest Diagnostics Revenue

Quest Diagnostics had revenue of $9.29B in the twelve months ending March 31, 2024, down -3.29% year-over-year. Revenue in the quarter ending March 31, 2024 was $2.37B with 1.50% year-over-year growth. In the year 2023, Quest Diagnostics had annual revenue of $9.25B, a decrease of -6.38%.

Revenue (ttm)
$9.29B
Revenue Growth
-3.29%
P/S Ratio
1.63
Revenue / Employee
$193,479
Employees
48,000
Market Cap
15.18B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20239.25B-631.00M-6.38%
Dec 31, 20229.88B-905.00M-8.39%
Dec 31, 202110.79B1.35B14.32%
Dec 31, 20209.44B1.71B22.15%
Dec 31, 20197.73B195.00M2.59%
Dec 31, 20187.53B129.00M1.74%
Dec 31, 20177.40B188.00M2.61%
Dec 31, 20167.21B-279.00M-3.72%
Dec 31, 20157.49B58.00M0.78%
Dec 31, 20147.44B289.00M4.04%
Dec 31, 20137.15B-237.00M-3.21%
Dec 31, 20127.38B-9.00M-0.12%
Dec 31, 20117.39B131.88M1.82%
Dec 31, 20107.26B-195.12M-2.62%
Dec 31, 20097.46B205.80M2.84%
Dec 31, 20087.25B544.54M8.12%
Dec 31, 20076.70B436.25M6.96%
Dec 31, 20066.27B811.93M14.88%
Dec 31, 20055.46B389.74M7.69%
Dec 31, 20045.07B329.03M6.94%
Dec 31, 20034.74B629.91M15.33%
Dec 31, 20024.11B480.28M13.24%
Dec 31, 20013.63B206.61M6.04%
Dec 31, 20003.42B1.22B55.14%
Dec 31, 19992.21B746.64M51.19%
Dec 31, 19981.46B-70.09M-4.58%
Dec 31, 19971.53B-87.60M-5.42%
Dec 31, 19961.62B-13.09M-0.80%
Dec 31, 19951.63B-4.31M-0.26%
Dec 31, 19941.63B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Baxter International 14.89B
Illumina 4.49B
Incyte 3.77B
BeiGene 2.76B
Genmab 2.57B
United Therapeutics 2.50B
BioMarin Pharmaceutical 2.47B
Neurocrine Biosciences 1.98B
Revenue Rankings